AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $210,000 | -75.4% | 6,400 | -61.2% | 0.00% | -50.0% |
| Q1 2021 | $852,000 | -36.3% | 16,500 | -56.8% | 0.00% | -50.0% |
| Q3 2020 | $1,337,000 | -20.2% | 38,200 | +8.8% | 0.00% | 0.0% |
| Q4 2019 | $1,676,000 | +523.0% | 35,100 | +550.0% | 0.00% | +300.0% |
| Q2 2019 | $269,000 | -82.9% | 5,400 | -84.2% | 0.00% | -75.0% |
| Q4 2018 | $1,577,000 | -24.0% | 34,200 | +27.1% | 0.00% | -20.0% |
| Q3 2018 | $2,075,000 | -65.0% | 26,900 | -61.8% | 0.01% | -68.8% |
| Q2 2018 | $5,930,000 | -21.4% | 70,400 | -23.7% | 0.02% | -20.0% |
| Q1 2018 | $7,548,000 | +23.6% | 92,300 | -13.6% | 0.02% | +25.0% |
| Q4 2017 | $6,106,000 | +114.7% | 106,800 | +150.7% | 0.02% | +100.0% |
| Q3 2017 | $2,844,000 | +30.4% | 42,600 | +0.5% | 0.01% | +14.3% |
| Q2 2017 | $2,181,000 | +0.4% | 42,400 | +14.0% | 0.01% | 0.0% |
| Q1 2017 | $2,172,000 | +61.1% | 37,200 | +15.2% | 0.01% | +40.0% |
| Q4 2016 | $1,348,000 | +82.4% | 32,300 | +130.7% | 0.01% | +66.7% |
| Q3 2016 | $739,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |